INFU
Infusystem·AMEX
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 4
Bearish signal 2
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About INFU
Infusystem Holdings, Inc.
A leading national health care service provider that facilitating outpatient care for durable medical equipment manufacturers and health care providers
Healthcare Equipment and Supplies
--
12/23/2010
American Stock Exchange
502
12-31
Common stock
3851 West Hamlin Road, Rochester Hills, Michigan 48309
--
Infusystem Holdings, Inc., founded in 2005, is located in Delaware. It operates through operating subsidiaries (including InfuSystem in California and First Biomedical in Kansas). The company is a leading provider of infusion pumps and related services for hospitals, oncology practices and institutions, and other mobile health care providers. The company's core business is to supply electronic flow infusion pumps and corresponding disposable supplies to tumor clinics, injection clinics and hospital chemotherapy clinics for the treatment of various cancers including colon cancer. The company's business strategy is to expand its business, referring to other cancer treatment areas, with opportunities to expand through strategic cooperation, joint ventures and/or acquisitions
Earnings Call
Q1/2025
Estimate EPS-0.03
Actual EPS-0.01
Estimate Revenue33.77M
Actual Revenue34.70M
Oncology Growth and IT Upgrade Costs: Contradictions from the 2025 Q1 Earnings Call
May 19,2025 05:27
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.04
Actual EPS0.12
Estimate Revenue36.14M
Actual Revenue36.00M
InfuSystem's Q2 2025 Earnings Call: Key Contradictions in Oncology Growth, Reimbursement Timelines, and Margin Sustainability
Aug 05,2025 11:26
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
INFU has released its 2025 Q3 earnings. EPS was reported at 0.11, versus the expected 0.05, beating expectations. The chart below visualizes how INFU has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
INFU has released its 2025 Q3 earnings report, with revenue of 36.49M, reflecting a YoY change of 3.31%, and net profit of 2.26M, showing a YoY change of 25.01%. The Sankey diagram below clearly presents INFU's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
